Radiation and Immune Checkpoint Blockade: From Bench to Clinic
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Radiology Nuclear Medicine and imaging,Oncology
Reference68 articles.
1. Hallmarks of cancer: The next generation;Hanahan;Cell,2011
2. Immune checkpoint blockade: A common denominator approach to cancer therapy;Topalian;Cancer Cell,2015
3. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi;N Engl J Med,2010
4. Pooled analysis of long-term survival data from phase II and phase III trials of ipilimumab in unresectable or metastatic melanoma;Schadendorf;J Clin Oncol,2015
5. Hodi FS, Sznol M, Carvajal R, et al: Durable, long-term survival in previously treated patients with advanced melanoma (MEL) who received nivolumab (NIVO) monotherapy in a phase I trial. AACR Annual Meeting. Abstract CT001; 2016. Presented April 17, 2016.
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Salvage radiotherapy in relapsed/refractory large B-cell lymphoma after failure of CAR T-cell therapy;Haematologica;2023-06-15
2. Synergizing radiotherapy and immunotherapy: Current challenges and strategies for optimization;Neoplasia;2023-02
3. Effect of Proton Therapy on Tumor Cell Killing and Immune Microenvironment for Hepatocellular Carcinoma;Cells;2023-01-15
4. Highly aneuploid non-small cell lung cancer shows enhanced responsiveness to concurrent radiation and immune checkpoint blockade;Nature Cancer;2022-11-28
5. Near complete remission of a locally advanced giant melanoma of the vulva following hypo‑fractionated radiotherapy and immune checkpoint inhibitors: A case report;Oncology Letters;2022-11-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3